ArticleMalawi medical journal : the journal of Medical Association of Malawi2025
Cardiovascular disease risk factors and the ten-year Cardiovascular disease risk among employees of a public university in Blantyre, Malawi.
Article in Malawi medical journal : the journal of Medical Association of Malawi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Systematic review and meta-analysis of cardiovascular disease risk among hypertensive patients in Africa.International journal of cardiology. Cardiovascular risk and prevention · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atherosclerotic Cardiovascular diseases (ASCVD) are the leading cause of death globally and disproportionately affect developing countries such as Malawi. Screening and management of significant ASCVD risk factors is essential. In Malawi, the prevalence of ASCVD risk factors among university staff, an economically important population, has not been well reported. This study investigated the prevalence of risk factors for ASCVDs and the ASCVD risk among employees of the Kamuzu University of Health Sciences, in Blantyre, Malawi. Methods: This was a cross-sectional study conducted in 2022 with 105 participants. Sociodemographic data, medical history, and anthropometric measurements were recorded. Blood samples were analyzed for HbA1C and serum lipids. Associated risk factors for ASCVD were assessed. The 10-year risk for ASCVD was calculated based on the Framingham Risk Table to predict 10-year cardiovascular outcomes. Statistical analysis included descriptive statistics and multivariate logistic regression to evaluate associations while adjusting for potential confounders. Results: Overweight and obesity were prevalent in 78% of the participants, while 43% and 42% of the participants had blood pressure readings in the pre-hypertension and hypertension categories, respectively. A proportion of 21% and 8% of the participants had HbA1c readings in the category of pre-diabetes and diabetes, respectively. Dyslipidaemia was detected in 72% of the participants. Regarding ASCVD risk, 58% had intermediate risk, while 13% had high risk. Being overweight or obese and age over 30 years predicted intermediate to high ASCVD risk (AOR 1.24 (95% CI 1.04 - 1.49) p=0.02, and (AOR 1.51 (95% CI 1.16 - 1.97) p < 0.01, 0.0001 respectively. Conclusion: This study reveals a high prevalence of ASCVD risk factors among KUHeS employees, with two-thirds of the population having an intermediate or high 10-year ASCVD risk. Routine screening and tailored management strategies are essential to reduce the ASCVD risk and burden in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.